demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
anti-inflammatory therapies
stem cells Shi Shu

3 studies excluded by filtering options 0

5093 PANAMO, 0 010selection pending
6007 COLCHIVID, 2021 110risk of bias not avaialble
9868 Brunetti, 2020 1110not a RCTrisk of bias not avaialble